2seventy bio, Inc. (TSVT)
NASDAQ: TSVT · Real-Time Price · USD
3.140
+0.220 (7.53%)
Dec 20, 2024, 4:00 PM EST - Market closed
2seventy bio Revenue
2seventy bio had revenue of $13.53M in the quarter ending September 30, 2024, with 12.46% growth. This brings the company's revenue in the last twelve months to $45.62M, down -68.73% year-over-year. In the year 2023, 2seventy bio had annual revenue of $100.39M with 9.72% growth.
Revenue (ttm)
$45.62M
Revenue Growth
-68.73%
P/S Ratio
3.58
Revenue / Employee
$166,496
Employees
274
Market Cap
161.99M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
ModivCare | 2.79B |
Adaptimmune Therapeutics | 175.04M |
Sutro Biopharma | 160.96M |
The Joint | 120.80M |
Pro-Dex | 56.80M |
Metagenomi | 55.08M |
Aligos Therapeutics | 6.00M |
TSVT News
- 5 weeks ago - 2seventy bio, Inc. (TSVT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - 2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress - Business Wire
- 6 weeks ago - 2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference - Business Wire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against 2seventy bio, Inc. (TSVT) And Encourages Shareholders to Reach Out - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against 2seventy bio, Inc. (TSVT) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating 2seventy bio, Inc. (TSVT) And Encourages Investors to Connect - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Encourages 2seventy bio, Inc. (TSVT) Stockholders to Inquire about Securities Investigation - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against 2seventy bio, Inc. (TSVT) And Encourages Stockholders to Reach Out - Accesswire